REGISTERED
on 03 Sep 2019
Last Applicant/ Owned by
3- 5º
Madrid
ES
E-28003
Serial Number
88033647 filed on 11th Jul 2018
Registration Number
5848628 registered on 03rd Sep 2019
Correspondent Address
Elizabeth Lee
Filing Basis
1. intent to use
Disclaimer
NO DATA
IRYVIZO
Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of dry eye syndrome; pharmaceutical preparations for the prevention of dry eye syndrome; collyrium; ophthalmic preparations; medicated gels, creams and solutions for eye use; medicat Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of dry eye syndrome; pharmaceutical preparations for the prevention of dry eye syndrome; collyrium; ophthalmic preparations; medicated gels, creams and solutions for eye use; medicated eye drops; medicated eye lotions; medicated eye sprays; medicated eye ointments
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88033647
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 20ABG-1017TM
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Sep 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 03rd Sep 2019 | REGISTERED-PRINCIPAL REGISTER |
| 18th Jun 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 18th Jun 2019 | PUBLISHED FOR OPPOSITION |
| 29th May 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 08th May 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th May 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 08th May 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th May 2019 | ASSIGNED TO LIE |
| 30th Apr 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |